Cargando…
Amide Analogues of CD1d Agonists Modulate iNKT-Cell-Mediated Cytokine Production
[Image: see text] Invariant natural killer T (iNKT) cells are restricted by the non-polymorphic MHC class I-like protein, CD1d, and activated following presentation of lipid antigens bound to CD1d molecules. The prototypical iNKT cell agonist is α-galactosyl ceramide (α-GalCer). CD1d-mediated activa...
Autores principales: | Wojno, Justyna, Jukes, John-Paul, Ghadbane, Hemza, Shepherd, Dawn, Besra, Gurdyal S., Cerundolo, Vincenzo, Cox, Liam R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2012
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409616/ https://www.ncbi.nlm.nih.gov/pubmed/22324848 http://dx.doi.org/10.1021/cb2005017 |
Ejemplares similares
-
Non‐glycosidic compounds can stimulate both human and mouse iNKT cells
por: Jukes, John‐Paul, et al.
Publicado: (2016) -
Design,
Synthesis, and Functional Activity of Labeled
CD1d Glycolipid Agonists
por: Jervis, Peter J., et al.
Publicado: (2013) -
Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
por: Veerapen, Natacha, et al.
Publicado: (2011) -
Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric α-galactosyl ceramide analogues
por: Jervis, Peter J., et al.
Publicado: (2012) -
Promotion or Suppression of Murine Intestinal Polyp Development by iNKT Cell Directed Immunotherapy
por: Wang, Ying, et al.
Publicado: (2019)